Drug Profile


Alternative Names: T4; Triptolide chlorohydrin

Latest Information Update: 06 Aug 1998

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Infertility therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Transplant rejection

Most Recent Events

  • 06 Aug 1998 No-Development-Reported for Transplant rejection in China (Unknown route)
  • 01 Sep 1995 A preclinical study has been added to the pharmacodynamics section
  • 11 May 1995 Preclinical development for Transplant rejection in China (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top